A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

Markers of Environmental Enteric Dysfunction Are Associated with Poor Growth and Developmental Outcomes among Young Children in Lusaka, Zambia




TekijätLauer, Jacqueline M.; Pyykkö, Juha; Chembe, Mpela; Bilima-Mulenga, Tamara; Sikazwe, Dorothy; Chibwe, Bertha; Henderson, Savanna; Parkerson, Doug; Leppänen, Jukka M.; Fink, Günther; Locks, Lindsey M.; Rockers, Peter C.

KustantajaElsevier BV

Julkaisuvuosi2025

JournalJournal of Pediatrics

Tietokannassa oleva lehden nimiThe Journal of Pediatrics

Artikkelin numero114408

Vuosikerta277

ISSN0022-3476

eISSN1097-6833

DOIhttps://doi.org/10.1016/j.jpeds.2024.114408

Verkko-osoitehttp://doi.org/10.1016/j.jpeds.2024.114408


Tiivistelmä

Objective
To examine cross-sectional relationships between biomarkers of environmental enteric dysfunction (EED), an acquired subclinical condition of the small intestine, and anthropometric and developmental outcomes among children in Lusaka, Zambia.

Study design
Serum samples were collected from 240 children ages 27 to 35 months enrolled in a cluster-randomized trial assessing the effects of growth charts and small-quantity lipid-based nutrient supplements on linear growth. Samples were analyzed using the 11-plex Micronutrient and EED Assessment Tool, which incorporates two biomarkers of EED, namely intestinal fatty acid-binding protein (I-FABP), a marker of epithelial damage, and soluble CD14 (sCD14), a marker of microbial translocation. Associations between log2-transformed biomarker concentrations and anthropometric (height-for-age z-score [HAZ], weight-for-height z-score, and weight-for-age z-score0 and developmental (Global Scales of Early Development [GSED] development for age z-score [DAZ] and saccadic reaction time [SRT]) outcomes were assessed using linear regression analyses adjusted for background characteristics.

Results
Mean ± SD HAZ was -1.94 ± 1.10. Higher sCD14 and I-FABP concentrations were significantly associated with lower HAZ (β: -0.21, 95% CI: -0.41, -0.01 and β: -0.20, 95% CI: -0.32, -0.08, respectively). Higher I-FABP concentrations were significantly associated with lower DAZ (β: -0.22, 95% CI: -0.40, -0.03) and slower SRT (β: 7.37 ms, 95% CI: 2.02, 12.72) as were higher alpha-1-acid glycoprotein concentrations (HAZ β: -0.38, 95% CI: -0.72, -0.03; SRT β: 11.14 ms, 95% CI: 0.94, 21.72).
​​​​​​​
Conclusions
In children in Lusaka, biomarkers of EED were associated with poor anthropometric and developmental outcomes, underscoring the need for interventions to address EED to improve child health globally.


Julkaisussa olevat rahoitustiedot
The parent trial was funded by Sint Antonius Stichting. The biomarkers sub-study was funded by CRI. JP was funded by the Osk. Huttunen Foundation, the Foundation for Pediatric Research in Finland, and the Finnish Cultural Foundation. The funders had no role in the study design, analysis, or interpretation of results.


Last updated on 2025-26-03 at 16:09